Ultragenyx Pharmaceutical Inc. Share Price

Ultragenyx Pharmaceutical Inc. Share Price

NASDAQ: RARE | Small Cap
$16.10
-$0.65 (-3.88%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ultragenyx Pharmaceutical Inc. Stock Performance

Open
$16.68
Prev. Close
$16.75
Circuit Range
N/A
Day Range
$15.92 - $16.89
Year Range
$12.73 - $39.38
Volume
2,15,243
Average Traded
$16.16

Ultragenyx Pharmaceutical Inc. Share Price Today

As of 31 October 2026, Ultragenyx Pharmaceutical Inc.'s share price is $16.10. The stock opened at $16.68, compared to its previous close of $16.75. During today's trading session, Ultragenyx Pharmaceutical Inc.'s share price traded between $15.92 and $16.89, with an average price of $16.41. Over the past 52 weeks, the stock has recorded a high of $39.38 and a low of $12.73. In terms of performance, Ultragenyx Pharmaceutical Inc.'s share price has declined by 34.78% over the last six months and is down 53.39% on a year-on-year basis.

Ultragenyx Pharmaceutical Inc. Share Price Chart

Line chart of the Ultragenyx Pharmaceutical Inc. price trend over the selected period. The price fell overall, ranging from 15.92 to 16.87, ending at 16.08.
$15.92$16.89
L
Show Current Price
H

Ultragenyx Pharmaceutical Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.59B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.94
Revenue (TTM)
$673.00B
Return On Equity (TTM)
201.36%
Profit Margin
-85.44%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
49.01%

Ultragenyx Pharmaceutical Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$159.93$207.28$136.00$214.00
Net Profit-$180.41-$128.56-$185.00-$92.00
Net Profit Margin-112.81%-62.02%-136.03%-42.99%
Income ChangeN/A28.74%-43.90%50.27%

Ultragenyx Pharmaceutical Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$363.33$434.00$560.00$673.00
Net Profit-$707.42-$607.00-$569.00-$575.00
Net Profit Margin-194.70%-139.86%-101.61%-85.44%
Income ChangeN/A14.20%6.26%-1.05%

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Ultragenyx Pharmaceutical Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$14.96
$16.09
+6.95%
Sep 2026
$25.37
$15.04
-42.73%
Aug 2026
$24.68
$26.27
+5.54%
Jul 2026
$33.31
$24.89
-25.47%
Jun 2026
$23.52
$33.40
+39.58%
May 2026
$24.97
$23.93
-3.08%
Apr 2026
$21.02
$24.68
+18.00%
Mar 2026
$22.52
$20.92
-10.52%
Feb 2026
$23.95
$23.38
-2.75%
Jan 2026
$22.89
$24.04
+4.50%
Dec 2025
$33.96
$23.00
-33.84%
Nov 2025
$34.20
$34.77
+0.67%

RARE Share Price FAQs